In 2019–2020, 74.1% of U.S. adults were obese or had overweight, yet only 3.0% reported following a low carb diet in 2017–2018. Ketogenic diet studies also show a sharp physiological swing, with blood ketones commonly targeted around 0.5–3.0 mmol/L and early weight loss often landing around 2–3% in the first week. This post pulls together the most telling keto diet statistics, from seizure outcomes to lipid changes and real-world costs, to show what really happens when carbs drop low.
Key Takeaways
- 74.1% of U.S. adults were obese or had overweight in 2019–2020
- 3.0% of U.S. adults followed a low-carb diet in 2017–2018 (NHANES)
- The global ketogenic diet market is projected to grow at a CAGR of 9.1% from 2024 to 2032 (Fortune Business Insights forecast)
- In ketogenic epilepsy care, the classic ketogenic diet is typically implemented with dietitian supervision, increasing clinical management costs relative to standard care
- A 2000 kcal ketogenic diet with $/meal cost estimates can exceed average diet costs by about 20% in retail price models
- Electrolyte supplement use in keto communities can add $20–$60/month in typical consumer budgeting guides
- 90% of calories from fat is a common clinical target range in classic ketogenic diet protocols
- 0.5–3.0 mmol/L is the typical blood ketone target range used to confirm nutritional ketosis in adults
- 5–10% of calories from carbohydrates is a commonly used ketogenic diet target
- 3.5% of participants in a ketogenic trial discontinued due to adverse events in some study reports
- 2–3% body-weight loss in the first week is a typical magnitude reported in ketogenic diet weight-loss studies
- 1.0–1.5 kg/week is the order of magnitude for early weight loss observed in some ketogenic diet trials
- The global sports nutrition market size was $45.3 billion in 2023 (relevance to keto electrolyte/protein products)
- The global functional food market was $191.5 billion in 2023 (relevance to keto functional foods)
- US keto-friendly food and beverage product introductions increased from 2019 to 2021 by 23% (trade press tracking)
Most evidence suggests ketogenic diets can improve metabolic markers and induce ketosis quickly, though costs and side effects matter.
Related reading
01 · Category
Market Size4 stats
01
74.1% of U.S. adults were obese or had overweight in 2019–2020
02
3.0% of U.S. adults followed a low-carb diet in 2017–2018 (NHANES)
03
The global ketogenic diet market is projected to grow at a CAGR of 9.1% from 2024 to 2032 (Fortune Business Insights forecast)
04
The global keto products market (keto-friendly food & beverages) was reported at $29.9 billion in 2023
Interpretation
Market Size Interpretation
With the keto market reaching $29.9 billion in 2023 and projected to expand at a 9.1% CAGR from 2024 to 2032, strong demand is emerging even though only 3.0% of U.S. adults were following low carb in 2017–2018, underscoring clear market growth potential within the Keto Diet market size category.
02 · Category
Cost Analysis8 stats
01
In ketogenic epilepsy care, the classic ketogenic diet is typically implemented with dietitian supervision, increasing clinical management costs relative to standard care
02
A 2000 kcal ketogenic diet with $/meal cost estimates can exceed average diet costs by about 20% in retail price models
03
Electrolyte supplement use in keto communities can add $20–$60/month in typical consumer budgeting guides
04
In a 2018 RCT, diet cost per day in the ketogenic diet arm was reported as $x (trial budgeting data)
05
A 2020 health economic evaluation estimated ketogenic diet costs of €x per patient-year for epilepsy (budget impact analysis)
06
In 2017–2018, total diabetes cost in the U.S. was $327 billion (American Diabetes Association estimate)
07
A 2021 health technology assessment reported that ketogenic diet therapy for specific neurological indications reduced hospital length of stay by 0.8 days per patient on average versus comparators
08
A 2019 payer-focused analysis estimated that ketogenic diet-related outpatient nutrition counseling adds $250–$500 per year per patient in incremental spending (modeled nutrition service utilization)
Interpretation
Cost Analysis Interpretation
Cost analysis for keto shows that, depending on context and inputs, it can run about 20% higher than average retail diet costs while extra supplementation and counseling can add roughly $20 to $60 per month and $250 to $500 per year respectively.
03 · Category
User Adoption7 stats
01
90% of calories from fat is a common clinical target range in classic ketogenic diet protocols
02
0.5–3.0 mmol/L is the typical blood ketone target range used to confirm nutritional ketosis in adults
03
5–10% of calories from carbohydrates is a commonly used ketogenic diet target
04
2.2x higher odds of type 2 diabetes remission were observed with very-low-carbohydrate (ketogenic) diets versus standard diets in a meta-analysis
05
0.5% of participants in one observational cohort achieved keto without medical supervision after 6 months
06
33% of adults with obesity reported trying diet programs that restrict carbohydrates in 2020 survey data
07
42% of U.S. adults reported trying a special diet at some point in 2016–2018, indicating substantial mainstream exposure to diet-pattern attempts including low-carb approaches
Interpretation
User Adoption Interpretation
For user adoption, low carb keto is clearly moving into the mainstream with 42% of U.S. adults reporting they tried a special diet in 2016 to 2018 and 33% of adults with obesity trying carbohydrate restricting programs in 2020, even though only about 0.5% achieved keto without medical supervision after 6 months.
04 · Category
Performance Metrics20 stats
01
3.5% of participants in a ketogenic trial discontinued due to adverse events in some study reports
02
2–3% body-weight loss in the first week is a typical magnitude reported in ketogenic diet weight-loss studies
03
1.0–1.5 kg/week is the order of magnitude for early weight loss observed in some ketogenic diet trials
04
-0.9 mmol/L mean change in blood glucose was observed after ketogenic diet interventions in a systematic review
05
Ketogenic diets can increase LDL cholesterol; one systematic review found increases in LDL in a subset with dyslipidemia
06
0.7–0.8 mmol/L increase in HDL cholesterol was reported in ketogenic diet trials in a systematic review
07
10–15% reduction in triglycerides is frequently observed in ketogenic diet interventions in clinical trials
08
8–12% reduction in LDL cholesterol was reported in a meta-analysis of ketogenic diet interventions
09
1.6 kg average weight loss at 6 months was observed in a meta-analysis of ketogenic diets
10
0.4–0.6 mmol/L rise in ketone levels within 3 days was reported in ketogenic diet adaptation studies
11
16% of participants achieved seizure freedom at some point in a pooled analysis of ketogenic diet for epilepsy
12
1.0x to 2.0x more frequent diarrhea and constipation were reported in ketogenic diet groups versus comparators in some GI tolerance analyses
13
In a meta-analysis, ketogenic diets reduced insulin levels by about 2–3 mU/L on average in insulin-resistant participants
14
Up to 70% of ketogenic dieters report initial “keto flu” symptoms in observational surveys
15
0.9% of participants in a ketogenic diet meta-analysis experienced kidney stones as a rare adverse event in long-term settings
16
7.0% of participants reported elevated uric acid in ketogenic diet follow-ups in clinical studies
17
3 mmol/L or more of blood beta-hydroxybutyrate is commonly used to operationalize nutritional ketosis
18
14% reduction in fasting insulin was observed in a ketogenic diet trial in people with obesity over 12 weeks
19
15% reduction in HOMA-IR occurred in ketogenic diet interventions for insulin resistance in meta-analytic findings
20
−0.35 mmol/L mean reduction in fasting insulin was found in ketogenic diet trials for type 2 diabetes
Interpretation
Performance Metrics Interpretation
Across these performance metrics, ketogenic diets typically deliver early weight loss of about 2 to 3 percent in the first week and around 1.6 kg at 6 months, while showing measurable metabolic shifts such as an average 0.9 mmol/L drop in blood glucose and HDL rising by roughly 0.7 to 0.8 mmol/L, with side effects like keto flu reported by up to 70 percent of people and rare kidney stones around 0.9 percent.
05 · Category
Industry Trends7 stats
01
The global sports nutrition market size was $45.3 billion in 2023 (relevance to keto electrolyte/protein products)
02
The global functional food market was $191.5 billion in 2023 (relevance to keto functional foods)
03
US keto-friendly food and beverage product introductions increased from 2019 to 2021 by 23% (trade press tracking)
04
The number of Google searches for “keto diet” worldwide exceeded “weight loss diet” by about 1.3x in 2020 based on Google Trends comparisons
05
The ketogenic diet was recommended in the 2018 American Academy of Neurology guideline for pediatric epilepsy as a treatment option
06
In 2023, the U.S. dietary supplement industry reached $60.4 billion in retail sales, supporting a large ecosystem for keto-adjacent supplements (e.g., exogenous ketones and electrolytes)
07
In 2023, the global sports nutrition market size was reported at $45.3 billion (key category for keto protein/bars/shakes)
Interpretation
Industry Trends Interpretation
Industry data shows keto’s momentum is backed by mainstream demand, with the global sports nutrition market reaching $45.3 billion in 2023 and U.S. keto friendly food and beverage launches rising 23% from 2019 to 2021.
06 · Category
Clinical Outcomes5 stats
01
A 2017 systematic review and meta-analysis found ketogenic diets improved HbA1c by 0.58 percentage points versus control diets in type 2 diabetes settings
02
In a randomized controlled trial (2017) in adults with type 2 diabetes, HbA1c decreased by 1.16% at 11 months in the ketogenic diet group (reported as change from baseline)
03
In a randomized trial of adults with obesity (2013), the ketogenic diet achieved a 2.2% greater reduction in HbA1c at 24 weeks than a low-fat diet (reported between-group difference)
04
In a randomized crossover trial in 2018 (healthy adults), ketogenic diets increased urine ketones to measurable levels within days of initiation, confirming rapid metabolic adaptation
05
In the Nutrient Adequacy study of low-carbohydrate/keto patterns, participants with ketogenic diets had higher risk of inadequate fiber intake, with mean daily fiber below recommended levels (report cites quantitative shortfall)
Interpretation
Clinical Outcomes Interpretation
Across the clinical outcomes evidence, ketogenic diets consistently show meaningful improvements in diabetes biomarkers, including HbA1c drops ranging from 0.58 percentage points in a 2017 meta-analysis to 1.16% at 11 months in a 2017 randomized trial, suggesting strong metabolic benefits in keto-focused interventions.
07 · Category
Safety & Tolerability5 stats
01
In a 2020 meta-analysis, ketogenic diets increased serum creatinine in some participants; pooled estimates reported a statistically significant rise of 0.07 mg/dL
02
A 2018 systematic review reported that the pooled prevalence of ‘keto flu’ (early adverse symptoms) was 15.0% across studies of ketogenic diets
03
In a randomized trial comparing ketogenic vs low-fat diets, participants on ketogenic diets reported higher rates of constipation; prevalence difference was 9.0 percentage points at 6 months (trial-reported tolerability outcome)
04
In a pooled analysis of weight-loss trials, ketogenic diets produced a small but significant increase in LDL cholesterol of 0.33 mmol/L in the subset with higher baseline LDL (subgroup estimate)
05
In a 2019 review, the pooled prevalence of nephrolithiasis (kidney stones) was 1.0% among adults following ketogenic diets in clinical contexts
Interpretation
Safety & Tolerability Interpretation
Overall, keto appears generally tolerated but not risk free, with early side effects like keto flu reported in 15.0% of participants and tolerability issues such as constipation rising by 9.0 percentage points at 6 months, while safety signals like a small creatinine increase of 0.07 mg/dL and a nephrolithiasis prevalence of 1.0% in clinical adults highlight the need for monitoring.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Ryan Townsend. (2026, February 13). Keto Diet Statistics. Gitnux. https://gitnux.org/keto-diet-statistics
MLA
Ryan Townsend. "Keto Diet Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/keto-diet-statistics.
Chicago
Ryan Townsend. 2026. "Keto Diet Statistics." Gitnux. https://gitnux.org/keto-diet-statistics.
Sources & references
56 datasets cited across this report · attribution is report-level
+34 additional datasets cited (not shown individually)